Colette Roche - Search Results

Year	Number of Results
2002	1
2003	1
2004	1
2007	1
2008	5
2009	2
2010	4
2011	3
2013	1
2014	1
2015	2
2016	1
2017	2
2018	1
2019	2
2020	1
2021	1
2024	1

1

Unifocal versus Multiple Ileal Neuroendocrine Tumors Location: An Embryological Origin.

Kalifi M, Walter T, Milot L, Hervieu V, Millot I, Gibert B, Roche C, Forestier J, Lombard-Bohas C, Pasquer A, Poncet G. Kalifi M, et al. Among authors: roche c. Neuroendocrinology. 2021;111(8):786-793. doi: 10.1159/000511849. Epub 2020 Sep 30. Neuroendocrinology. 2021. PMID: 32998140 Free article.

2

Neuropilin-2 and soluble neuropilin-2 in neuroendocrine neoplasms.

Gerard L, Patte C, Chardon L, Hervieu V, Payen L, Allio M, Marx C, Clermidy H, Durand A, Mehlen P, Bollard J, Poncet G, Roche C, Gibert B, Walter T. Gerard L, et al. Among authors: roche c. Endocr Relat Cancer. 2024 Apr 1:ERC-24-0052. doi: 10.1530/ERC-24-0052. Online ahead of print. Endocr Relat Cancer. 2024. PMID: 38642579

3

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases.

Imperiale A, Poncet G, Addeo P, Ruhland E, Roche C, Battini S, Cicek AE, Chenard MP, Hervieu V, Goichot B, Bachellier P, Walter T, Namer IJ. Imperiale A, et al. Among authors: roche c. Metabolites. 2019 Dec 11;9(12):300. doi: 10.3390/metabo9120300. Metabolites. 2019. PMID: 31835679 Free PMC article.

4

Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors.

Bollard J, Patte C, Radkova K, Massoma P, Chardon L, Valantin J, Gadot N, Goddard I, Vercherat C, Hervieu V, Gouysse G, Poncet G, Scoazec JY, Walter T, Roche C. Bollard J, et al. Among authors: roche c. J Pathol. 2019 Nov;249(3):343-355. doi: 10.1002/path.5321. Epub 2019 Sep 3. J Pathol. 2019. PMID: 31257576

5

Angiogenesis and tumor progression in neuroendocrine digestive tumors.

Poncet G, Villaume K, Walter T, Pourreyron C, Theillaumas A, Lépinasse F, Hervieu V, Cordier-Bussat M, Scoazec JY, Roche C. Poncet G, et al. Among authors: roche c. J Surg Res. 2009 Jun 1;154(1):68-77. doi: 10.1016/j.jss.2008.03.055. Epub 2008 Apr 29. J Surg Res. 2009. PMID: 18708196

6

mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines.

Freis P, Bollard J, Lebeau J, Massoma P, Fauvre J, Vercherat C, Walter T, Manié S, Roche C, Scoazec JY, Ferraro-Peyret C. Freis P, et al. Among authors: roche c. Oncotarget. 2017 Mar 28;8(13):20974-20987. doi: 10.18632/oncotarget.15469. Oncotarget. 2017. PMID: 28423496 Free PMC article.

7

Antitumor effect of everolimus in preclinical models of high-grade gastroenteropancreatic neuroendocrine carcinomas.

Bollard J, Couderc C, Blanc M, Poncet G, Lepinasse F, Hervieu V, Gouysse G, Ferraro-Peyret C, Benslama N, Walter T, Scoazec JY, Roche C. Bollard J, et al. Among authors: roche c. Neuroendocrinology. 2013;97(4):331-40. doi: 10.1159/000347063. Epub 2013 May 22. Neuroendocrinology. 2013. PMID: 23343749 Free article.

8

Relation between menin expression and NF-kappaB activity in an intestinal cell line.

Theillaumas A, Blanc M, Couderc C, Poncet G, Bazzi W, Bernard C, Cordier-Bussat M, Scoazec JY, Roche C. Theillaumas A, et al. Among authors: roche c. Mol Cell Endocrinol. 2008 Sep 10;291(1-2):109-15. doi: 10.1016/j.mce.2008.05.019. Epub 2008 Jun 11. Mol Cell Endocrinol. 2008. PMID: 18590796

9

Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors.

Benslama N, Bollard J, Vercherat C, Massoma P, Roche C, Hervieu V, Peron J, Lombard-Bohas C, Scoazec JY, Walter T. Benslama N, et al. Among authors: roche c. Invest New Drugs. 2016 Oct;34(5):654-62. doi: 10.1007/s10637-016-0363-6. Epub 2016 May 26. Invest New Drugs. 2016. PMID: 27230034

10

Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic In Vitro and In Vivo Antitumor Effects in Insulinoma Cells.

Bollard J, Patte C, Massoma P, Goddard I, Gadot N, Benslama N, Hervieu V, Ferraro-Peyret C, Cordier-Bussat M, Scoazec JY, Roche C, Walter T, Vercherat C. Bollard J, et al. Among authors: roche c. Mol Cancer Ther. 2018 Jan;17(1):60-72. doi: 10.1158/1535-7163.MCT-17-0325. Epub 2017 Oct 19. Mol Cancer Ther. 2018. PMID: 29051320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year